关于COVID-19疫苗与神经疾病 (COVIVAX) 之间的关联的多中心病例控制研究
Elisabetta Pupillo1, Elisa Bianchi1, Ettore Beghi1
1Dipartimento di Neuroscienze, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Scientific reports
|February 5, 2025
概括
接种COVID-19疫苗并没有增加神经系统疾病的风险. 在COVIVAX研究中发现,多剂量疫苗对老年人中风具有潜在的保护作用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 对于COVID-19疫苗的神经安全性存在担忧.
- 了解疫苗接种与神经系统疾病之间的关联对于公共卫生指导至关重要.
研究的目的:
- 评估COVID-19疫苗接种与新发的神经疾病风险之间的关联.
- 研究疫苗接种在特定人群中的潜在保护作用.
主要方法:
- 多中心病例控制研究 (COVIVAX).
- 在265个神经疾病病例和265个匹配的对照中比较疫苗接种情况.
- 分析的数据经过调整以考虑混因素.
主要成果:
- 与COVID-19疫苗接种无关的神经系统疾病的风险增加.
- 多个疫苗剂量显示,在60岁以上的个体中,对中风有潜在的保护作用.
- 接种疫苗与那些患有并发症和中风的风险降低有关.
结论:
- 接种COVID-19疫苗似乎不会增加常见神经系统疾病的风险.
- 需要进一步的研究来确认COVID-19疫苗对老年人中风的保护作用.
相关概念视频
Vaccinations
43.9K
Overview
43.9K
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Bias in Epidemiological Studies
141
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
141


